← Retour au Screener

Sector: Santé
Open in Terminal → NHCLive chart · Key metrics · News · Smart money

National HealthCare Corporation

NHC Mid Cap

Healthcare · Medical Care Facilities

Mis à jour: Jun 18, 2026, 22:21 UTC

175,84 €
+5.55% aujourd'hui
52W: 81,54 € – 179,50 €
52W Low: 81,54 € Position: 96.3% 52W High: 179,50 €

Price Chart

Indicateurs clés

P/E Ratio
25.63x
Cours/Bénéfice
Forward P/E
469.08x
P/E prévisionnel
P/S Ratio
2.06x
Cours/Ventes
EV/EBITDA
15.88x
Valeur d'entreprise/EBITDA
Rend. dividende
1.28%
Rendement annuel du dividende
Cap. boursière
2,7 Md €
Capitalisation boursière
Croissance du CA
2.2%
Croissance du CA sur un an
Marge bénéficiaire
8.1%
Marge nette
ROE
12.01%
Rentabilité des capitaux propres
Beta
0.67
Sensibilité au marché
Positions vendeuses
4.7%
% du flottant vendu à découvert
Volume moyen
123,060
Volume quotidien moyen

Valuation Analysis

Signal
Fair
vs. S&P 500 avg P/E (24.7x)
Analyst Consensus
None
0 analysts

About the Company

Sector: Healthcare Industry: Medical Care Facilities Country: United States Employees: 15,278 Exchange: ASE

National HealthCare Corporation en bref

National HealthCare Corporation (NHC) is currently trading at 175,84 € with a market capitalization of 2,7 Md €. The trailing P/E ratio stands at 25.63x, with a forward P/E of 469.08x. The 52-week range spans from 81,54 € to 179,50 €; the current price is 2% below the yearly high. Year-over-year revenue growth stands at +2.2%. The net profit margin stands at 8.1%.

💰 Dividende

National HealthCare Corporation pays an annual dividend of 2,26 € per share, representing a yield of 1.28%. The payout ratio stands at 32.53%.

National HealthCare Corporation : la thèse d'investissement en détail

National HealthCare Corporation (NHC) operates in the Healthcare — specifically Medical Care Facilities — and is headquartered in United States. Below is a structured read of the investment case built directly from the latest fundamentals, valuation multiples, analyst positioning and smart-money flows. Each section translates raw numbers into the investment logic they imply, so you can decide whether the risk/reward fits your portfolio.

Le scénario baissier

Revenue growth has slowed to just 2.2%, which is below nominal GDP — the business is no longer outgrowing the broader economy.

Valorisation en contexte

With a PEG ratio of 0.82, the price-to-earnings multiple is actually below the company's growth rate — classic value-meets-growth territory that Peter Lynch would have called a 'GARP' opportunity.

À surveiller

  • The share is trading at 96.3% of its 52-week range — a break above the recent high opens technical upside, a failure here often invites profit-taking.

Thèse d'investissement : forces et faiblesses

Points forts
  • Bilan solide avec faible endettement (D/E 3.58)
  • Free cash flow positif
Points faibles
  • Cours proche du plus haut 52 semaines — faible marge de hausse

Aperçu technique

MM 50 jours
158,69 €
+10.81% vs. cours
MM 200 jours
130,15 €
+35.11% vs. cours
Sous le plus haut 52s
−2%
179,50 €
Au-dessus du plus bas 52s
+115.6%
81,54 €

Price trades above both the 50- and 200-day moving averages, with 50d above 200d — a classic bullish setup (golden-cross alignment).

Profil de risque

Risque de marché (Bêta)
0.67 · Défensive
Évolue moins que le marché global
Positions vendeuses
4.7% · Faible
% du flottant vendu à découvert
Dette/Capitaux propres
3.58 · Faible
Dette totale / capitaux propres

The data points to relatively defensive market behavior.

Trading Data

50-Day MA: 158,69 €
200-Day MA: 130,15 €
Volume: 308,112
Avg. Volume: 123,060
Short Ratio: 5.85
P/B Ratio: 2.89x
Debt/Equity: 3.58x
Free Cash Flow: 103 M €

💵 Dividend Info

Dividend Yield
1.28%
Annual Rate
2,26 €
Payout Ratio
32.53%

More Santé stocks

Top peers in the same sector — ranked by market cap.

View full Santé sector page →

Where can I buy National HealthCare Corporation?

Compare top-rated brokers — low fees, trusted providers, fully regulated.

Live Market Data

Real-time chart, financials, earnings, analysts, insider trades, events & news

Financials

Earnings

Analyst Ratings

Insider Trades

Events Timeline

News + Sentiment

Peer Comparison

Scroll to Top